Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users

Drug and Alcohol Dependence

Volumn 161, Issue , 2016, Pages 163-170

  Okita, Kyoji ^a,e   Ghahremani, Dara G ^a   Payer, Doris E ^c,d   Robertson, Chelsea L ^a,e   Dean, Andy C ^a   Mandelkern, Mark A ^e,f   London, Edythe D ^a,b,e  

^a Department of Psychiatry and Biobehavioral Sciences ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amygdala; Dopamine; Emotion dysregulation; Methamphetamine; PET; 18F Fallypride

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FALLYPRIDE; FLUORINE 18; METHAMPHETAMINE; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; DOPAMINE; FLUORINE;

ADDICTION SEVERITY INDEX; ADULT; AMYGDALA; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFICULTIES IN EMOTION REGULATION SCALE; DISEASE ASSOCIATION; EMOTION ASSESSMENT; EMOTIONAL DISORDER; EMOTIONALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROBLEM BEHAVIOR; RECEPTOR BINDING; AMPHETAMINE DEPENDENCE; CASE CONTROL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMOTION; METABOLISM; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; RADIOASSAY;

ADULT; AMPHETAMINE-RELATED DISORDERS; AMYGDALA; BENZAMIDES; CASE-CONTROL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOPAMINE; EMOTIONS; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHAMPHETAMINE; MIDDLE AGED; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D2;

EID: 84957653636     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.01.029     Document Type: Article

References (68)

1. al'Absi M., Carr S.B., Bongard S. Anger and psychobiological changes during smoking abstinence and in response to acute stress: prediction of smoking relapse. J. Psychophysiol. 2007, 66:109-115.
2. Alleweireldt A.T., Hobbs R.J., Taylor A.R., Neisewander J.L. Effects of SCH-23390 infused into the amygdala or adjacent cortex and basal ganglia on cocaine seeking and self-administration in rats. Neuropsychopharmacology 2006, 31:363-374.
3. Badgaiyan R.D. Imaging dopamine neurotransmission in live human brain. Prog. Brain Res. 2014, 211:165-182.
4. Badgaiyan R.D., Fischman A.J., Alpert N.M. Dopamine release during human emotional processing. Neuroimage 2009, 47:2041-2045.
5. Berking M., Margraf M., Ebert D., Wupperman P., Hofmann S.G., Junghanns K. Deficits in emotion-regulation skills predict alcohol use during and after cognitive-behavioral therapy for alcohol dependence. J. Consult Clin. Psychol. 2011, 79:307-318.
6. Bissiere S., Humeau Y., Luthi A. Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition. Nat. Neurosci. 2003, 6:587-592.
7. Brown A.K., Mandelkern M.A., Farahi J., Robertson C., Ghahremani D.G., Sumerel B., Moallem N., London E.D. Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers. Int. J. Neuropsychopharmacol. 2012, 15:989-994.
8. Ciliax B.J., Drash G.W., Staley J.K., Haber S., Mobley C.J., Miller G.W., Mufson E.J., Mash D.C., Levey A.I. Immunocytochemical localization of the dopamine transporter in human brain. J. Comp. Neurol. 1999, 409:38-56.
9. Dean A.C., Kohno M., Hellemann G., London E.D. Childhood maltreatment and amygdala connectivity in methamphetamine dependence: a pilot study. Brain Behav. 2014, 4:867-876.
10. Desikan R.S., Ségonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., Buckner R.L., Dale A.M., Maguire R.P., Hyman B.T., Albert M.S., Killiany R.J. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006, 31:968-980.
11. Diaz M.R., Chappell A.M., Christian D.T., Anderson N.J., McCool B.A. Dopamine D3-like receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral/basolateral amygdala. Neuropsychopharmacology 2011, 36:1090-1103.
12. Donegan N.H., Sanislow C.A., Blumberg H.P., Fulbright R.K., Lacadie C., Skudlarski P., Gore J.C., Olson I.R., McGlashan T.H., Wexler B.E. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol. Psychiatry 2003, 54:1284-1293.
13. Fallon J.H., Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 1978, 180:545-580.
14. Fox H.C., Axelrod S.R., Paliwal P., Sleeper J., Sinha R. Difficulties in emotion regulation and impulse control during cocaine abstinence. Drug Alcohol Depend. 2007, 89:298-301.
15. Fox H.C., Hong K.A., Sinha R. Difficulties in emotion regulation and impulse control in recently abstinent alcoholics compared with social drinkers. Addict. Behav. 2008, 33:388-394.
16. Frank D.W., Dewitt M., Hudgens-Haney M., Schaeffer D.J., Ball B.H., Schwarz N.F., Hussein A.A., Smart L.M., Sabatinelli D. Emotion regulation: quantitative meta-analysis of functional activation and deactivation. Neurosci. Biobehav. Rev 2014, 45:202-211.
17. Ghahremani D.G., Lee B., Robertson C.L., Tabibnia G., Morgan A.T., De Shetler N., Brown A.K., Monterosso J.R., Aron A.R., Mandelkern M.A., Poldrack R.A., London E.D. Striatal dopamine D(2)/D(3) receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J. Neurosci. 2012, 32:7316-7324.
18. Grace A.A., Rosenkranz J.A. Regulation of conditioned responses of basolateral amygdala neurons. Physiol. Behav. 2002, 77:489-493.
19. Gratz K., Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the Difficulties in Emotion Regulation Scale. J. Psychopathol. Behav. Assess. 2004, 26:41-54.
20. Greba Q., Gifkins A., Kokkinidis L. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle. Brain Res. 2001, 899:218-226.
21. Gross J.J. Handbook of Emotion Regulation 2015, Guilford Publications.
22. Guarraci F.A., Frohardt R.J., Falls W.A., Kapp B.S. The effects of intra-amygdaloid infusions of a D2 dopamine receptor antagonist on Pavlovian fear conditioning. Behav. Neurosci. 2000, 114:647-651.
23. Gyurak A., Gross J.J., Etkin A. Explicit and implicit emotion regulation: a dual-process framework. Cogn. Emot. 2011, 25:400-412.
24. Hariri A.R., Mattay V.S., Tessitore A., Fera F., Smith W.G., Weinberger D.R. Dextroamphetamine modulates the response of the human amygdala. Neuropsychopharmacology 2002, 27:1036-1040.
25. Hilt L.M., Hanson J.L., Pollak S.D. Emotion dysregulation. Encyclopedia of Adolescence 2011, 160-169. Academic Press, San Diego. B.B.B.J. Prinstein (Ed.).
26. Hodgins D.C., el-Guebaly N., Armstrong S. Prospective and retrospective reports of mood states before relapse to substance use. J. Consult. Clin. Psychol. 1995, 63:400-407.
27. Ito H., Kodaka F., Takahashi H., Takano H., Arakawa R., Shimada H., Suhara T. Relation between presynaptic and postsynaptic dopaminergic functions measured by positron emission tomography: implication of dopaminergic tone. J. Neurosci. 2011, 31:7886-7890.
28. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002, 17:825-841.
29. Jerjian T., Constantinescu C., Sevrioukov E., Mukherjee J. Evaluation of dopamine D3 receptor binding of 18F-fallypride. J. Nucl. Med. (Meeting Abstracts) 2010, 51:1762.
30. Kanske P., Heissler J., Schonfelder S., Bongers A., Wessa M. How to regulate emotion? Neural networks for reappraisal and distraction. Cereb. Cortex 2011, 21:1379-1388.
31. Kohno M., Ghahremani D.G., Morales A.M., Robertson C.L., Ishibashi K., Morgan A.T., Mandelkern M.A., London E.D. Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity. Cereb. Cortex 2015, 25:236-245.
32. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. Neuroimage 1996, 4:153-158.
33. Lee B., London E.D., Poldrack R.A., Farahi J., Nacca A., Monterosso J.R., Mumford J.A., Bokarius A.V., Dahlbom M., Mukherjee J., Bilder R.M., Brody A.L., Mandelkern M.A. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J. Neurosci. 2009, 29:14734-14740.
34. London E.D., Kohno M., Morales A.M., Ballard M.E. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res. 2014, 1628:174-185.
35. London E.D., Simon S.L., Berman S.M., Mandelkern M.A., Lichtman A.M., Bramen J., Shinn A.K., Miotto K., Learn J., Dong Y., Matochik J.A., Kurian V., Newton T., Woods R., Rawson R., Ling W. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch. Gen. Psychiatry 2004, 61:73-84.
36. Mantsch J.R., Baker D.A., Funk D., Le A.D., Shaham Y. Stress-induced reinstatement of drug seeking: 20 years of progress. Neuropsychopharmacology 2015, 41:335-356.
37. Martinez D., Greene K., Broft A., Kumar D., Liu F., Narendran R., Slifstein M., Van Heertum R., Kleber H.D. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. Am. J. Psychiatry 2009, 166:1170-1177.
38. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 1992, 9:199-213.
39. McRae K., Hughes B., Chopra S., Gabrieli J.D., Gross J.J., Ochsner K.N. The neural bases of distraction and reappraisal. J. Cogn. Neurosci. 2010, 22:248-262.
40. Mukherjee J., Christian B.T., Dunigan K.A., Shi B., Narayanan T.K., Satter M., Mantil J. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 2002, 46:170-188.
41. Mukherjee J., Yang Z.Y., Das M.K., Brown T. Fluorinated benzamide neuroleptics-III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl) methyl]-5-(3-[18F]fluoropropyl)-2: 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Nucl. Med. Biol. 1995, 22:283-296.
42. Murray R.J., Brosch T., Sander D. The functional profile of the human amygdala in affective processing: insights from intracranial recordings. Cortex 2014, 60:10-33.
43. Narendran R., Frankle W.G., Mason N.S., Rabiner E.A., Gunn R.N., Searle G.E., Vora S., Litschge M., Kendro S., Cooper T.B., Mathis C.A., Laruelle M. Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 2009, 63:447-461.
44. Newton T.F., Kalechstein A.D., Duran S., Vansluis N., Ling W. Methamphetamine abstinence syndrome: preliminary findings. Am. J. Addict. 2004, 13:248-255.
45. Ochsner K.N., Ray R.R., Hughes B., McRae K., Cooper J.C., Weber J., Gabrieli J.D., Gross J.J. Bottom-up and top-down processes in emotion generation: common and distinct neural mechanisms. Psychol. Sci. 2009, 20:1322-1331.
46. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
47. Olsson H., Halldin C., Swahn C.G., Farde L. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J. Cereb. Blood Flow Metab. 1999, 19:1164-1173.
48. Patenaude B., Smith S.M., Kennedy D.N., Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage 2011, 56:907-922.
49. Payer D.E., Lieberman M.D., London E.D. Neural correlates of affect processing and aggression in methamphetamine dependence. Arch. Gen. Psychiatry 2011, 68:271-282.
50. Phelps E.A. Emotion and cognition: insights from studies of the human amygdala. Annu. Rev. Psychol. 2006, 57:27-53.
51. Phelps E.A., Anderson A.K. Emotional memory: what does the amygdala do?. Curr. Biol. 1997, 7:R311-R314.
52. Preacher K., Hayes A. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Methods 2008, 40:879-891.
53. Preston K.L., Epstein D.H. Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use. Psychopharmacology 2011, 218:29-37.
54. Prieto E., Marti-Climent J.M., Arbizu J., Garrastachu P., Dominguez I., Quincoces G., Garcia-Velloso M.J., Lecumberri P., Gomez-Fernandez M., Richter J.A. Evaluation of spatial resolution of a PET scanner through the simulation and experimental measurement of the recovery coefficient. Comput. Biol. Med. 2010, 40:75-80.
55. Rosenkranz J.A., Grace A.A. Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J. Neurosci. 1999, 19:11027-11039.
56. Schaefer S.M., Jackson D.C., Davidson R.J., Aguirre G.K., Kimberg D.Y., Thompson-Schill S.L. Modulation of amygdalar activity by the conscious regulation of negative emotion. J. Cogn. Neurosci. 2002, 14:913-921.
57. Scott L.N., Stepp S.D., Pilkonis P.A. Prospective associations between features of borderline personality disorder emotion dysregulation, and aggression. Personal. Disord. 2014, 5:278-288.
58. Shen W., Liu Y., Li L., Zhang Y., Zhou W. Negative moods correlate with craving in female methamphetamine users enrolled in compulsory detoxification. Subst. Abuse Treat. Prev. Policy 2012, 7:44.
59. Takahashi H., Takano H., Kodaka F., Arakawa R., Yamada M., Otsuka T., Hirano Y., Kikyo H., Okubo Y., Kato M., Obata T., Ito H., Suhara T. Contribution of dopamine D1 and D2 receptors to amygdala activity in human. J. Neurosci. 2010, 30:3043-3047.
60. Vandehey N.T., Moirano J.M., Converse A.K., Holden J.E., Mukherjee J., Murali D., Nickles R.J., Davidson R.J., Schneider M.L., Christian B.T. High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol. J. Cereb. Blood Flow Metab. 2010, 30:994-1007.
61. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 2001, 158:2015-2021.
62. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56(Suppl. 1):3-8.
63. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D., Telang F. Addiction: beyond dopamine reward circuitry. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:15037-15042.
64. Vuilleumier P. How brains beware: neural mechanisms of emotional attention. Trends Cogn. Sci. 2005, 9:585-594.
65. Weiss N.H., Sullivan T.P., Tull M.T. Explicating the role of emotion dysregulation in risky behaviors: a review and synthesis of the literature with directions for future research and clinical practice. Curr. Opin. Psychol. 2015, 3:22-29.
66. Wu Y., Carson R.E. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow Metab. 2002, 22:1440-1452.
67. Zorick T., Lee B., Mandelkern M.A., Fong T., Robertson C., Ghahremani D.G., Brown A.K., Sumerel B., London E.D. Low striatal dopamine receptor availability linked to caloric intake during abstinence from chronic methamphetamine abuse. Mol. Psychiatry 2012, 17:569-571.
68. Zweben J.E., Cohen J.B., Christian D., Galloway G.P., Salinardi M., Parent D., Iguchi M., Methamphetamine Treatment P. Psychiatric symptoms in methamphetamine users. Am. J. Addict. 2004, 13:181-190.